Alphabet’s Isomorphic Labs raised $5 billion to accelerate AI-assisted drug discovery, one of the largest financing rounds yet for computational biology. The capital signals investor confidence that models can move beyond generating text toward identifying therapeutic targets and designing molecules, despite the long clinical validation cycle. For both technology and pharmaceuticals, the round raises the stakes around proprietary biological data, lab integration and measurable pipeline results. Biology just closed a mega-round 😉
Sage S2.1 Flash introduced a 320-billion-parameter general-purpose mixture-of-experts model built to reason over scientific evidence and act in dynamic environments. Specialized encoders for molecular graphs and biological data distinguish it from general chat systems, potentially making agentic workflows more useful in research. Its scale also underscores the compute and data demands of scientific AI, where domain representations can matter as much as fluent language. The lab coat now has 320 billion pockets 😉